Prof Graham Ball is Professor of Bioinformatics at Nottingham Trent University and CSO of CompanDX UK and CompanDX China Ltd. He is Associate Director the John Van Geest Cancer Research Centre and biostatistics lead on three clinical projects. He has been involved in the development and validation of bioinformatics algorithms using Artificial Neural Networks for the last 18 years. He has 230 journal papers and 5 patents in this area. His current research is focused on characterization of biological systems, including diagnostic and classification modelling of cancer molecular pathology, host response to disease and identification of molecular targets for therapy.
Artificial Intelligence Algorithms For Biomarker Discovery, Therapeutic Target Discovery and Pathway Modelling.